These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35117209)

  • 1. Different prognosis by subtype in the early mucinous breast cancer: a SEER population-based analysis.
    Lian W; Zheng J; Chen D
    Transl Cancer Res; 2020 Oct; 9(10):5969-5978. PubMed ID: 35117209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
    Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
    BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
    Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
    Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
    Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
    Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of progesterone receptor on metastasis and prognosis in breast cancer patients with negative HER-2.
    Xiao Y; Li J; Wu Z; Zhang X; Ming J
    Gland Surg; 2022 Jan; 11(1):77-90. PubMed ID: 35242671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Analysis of Primary Breast Signet Ring Cell Carcinoma and Mucinous Breast Adenocarcinoma: A SEER Population-Based Study.
    Wang S; Zhang Y; Yin F; Zhang X; Yang Z; Wang X
    Front Oncol; 2021; 11():783631. PubMed ID: 34956901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database.
    Qiu R; Zhao W; Yang J; Shen Y; Wang B; Li P; Zhao A; Tian Q; Zhang M; Yi M; Yang J; Dong D
    J Breast Cancer; 2019 Jun; 22(2):297-310. PubMed ID: 31281731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
    Nelson RA; Guye ML; Luu T; Lai LL
    Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
    Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
    Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
    Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
    Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
    PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis.
    Zhan Q; Zhao X; Zheng G; Liu J; Wu S; Huang J; Yu L; Fu F
    Oncol Res Treat; 2023; 46(12):511-519. PubMed ID: 37931609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.